Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.34 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL417319 | 0.92 | CHRM2 (0.47) | CHRM2CHRM4CHRM3SLC6A2TP53 | |
| SCHEMBL30849529 | 0.92 | CHRM2 (0.47) | CHRM2CHRM4CHRM3SLC6A2TP53 | |
| SCHEMBL31010892 | 0.84 | CHRM2 (0.47) | CHRM2CHRM4CHRM3SLC6A2SLC6A4 | |
| SCHEMBL29726716 | 0.84 | CHRM2 (0.47) | CHRM2CHRM4CHRM3SLC6A2SLC6A4 | |
| SCHEMBL19250570 | 0.84 | CHRM2 (0.47) | CHRM2CHRM4CHRM3SLC6A2SLC6A4 | |
| SCHEMBL5593742 | 0.83 | TP53 (0.33) | TP53 | |
| SCHEMBL237267 | 0.81 | ALDH1A1 (0.36) | TP53 | |
| SCHEMBL27581302 | 0.80 | CHRM2 (0.41) | CHRM2CHRM4CHRM3 | |
| SCHEMBL22188917 | 0.80 | CHRNB2 (0.43) | CHRM2CHRM4CHRM3SLC6A2SLC6A4 | |
| SCHEMBL11514730 | 0.80 | CHRM2 (0.48) | CHRM2CHRM4CHRM3SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230359119-A1 | RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| CN-103402989-B | Tetrazole compound and preparation and application thereof | ZAFGEN CORP. (US) | 2016-04-06 | — | — | CN | disclosed |
| EP-2009304-B1 | TORQUE LIMITER | JTEKT CORP (JP) | 2014-10-01 | — | — | EP | disclosed |
| EP-2003353-B1 | TORQUE LIMITER | JTEKT CORP (JP) | 2014-06-04 | — | — | EP | disclosed |
| CN-103402989-A | Tetrazole compounds and methods of making and using same | ZAFGEN CORP | 2013-11-20 | — | — | CN | disclosed |
| US-8230986-B2 | Torque limiter | JTEKT CORPORATION (JP) | 2012-07-31 | — | — | US | disclosed |
| US-8220609-B2 | Torque limiter | JTEKT CORPORATION (JP) | 2012-07-17 | — | — | US | disclosed |
| US-20100184519-A1 | TORQUE LIMITER | JTEKT CORPORATION (JP) | 2010-07-22 | — | — | US | disclosed |
| US-20090173591-A1 | TORQUE LIMITER | JTEKT CORPORATION (JP) | 2009-07-09 | — | — | US | disclosed |
| EP-2009304-A1 | TORQUE LIMITER | JTEKT Corporation (JP) | 2008-12-31 | — | — | EP | disclosed |
| EP-2003353-A1 | TORQUE LIMITER | JTEKT Corporation (JP) | 2008-12-17 | — | — | EP | disclosed |
| CN-1805957-A | Azetidine compounds | ASTRAZENECA AB (SE) | 2006-07-19 | — | — | CN | disclosed |
| CN-1359373-A | 6- [ [ (aryl and heteroaryl) oxy ] methyl ] -naphthyl-2-carboximidamide derivatives, process for their preparation and their use in therapy | SANOFI SYNTHELABO (FR) | 2002-07-17 | — | — | CN | disclosed |
| CN-1193012-A | Sulfamine-substituted chemical compound, preparing process therefor, and use as medicine and diagnosis agent and medicine containing same | HOECHST AG (DE) | 1998-09-16 | — | — | CN | disclosed |
| WO-1993004070-A1 | SUBSTITUTED ACRYLAMIDO-PENICILLANIC ACID DERIVATIVES | SMITHKLINE BEECHAM, PLC (GB) | 1993-03-04 | — | — | WO | disclosed |
| EP-0421752-A2 | Substituted acrylamido-penicillanic acid derivatives | Beecham Group p.l.c. (GB) | 1991-04-10 | — | — | EP | disclosed |